Staar Surgical Capital Expenditures (CapEx) Growth & History (STAA)
Staar Surgical's capital expenditures (capex) was $5.8M for fiscal 2025.
View full Staar Surgical company overviewStaar Surgical annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2026-01-02 | $5.8M | −$17.6M | −75.12% |
| 2024 | 2024-12-27 | $23.4M | $5.2M | +28.62% |
| 2023 | 2023-12-29 | $18.2M | $80,000 | +0.44% |
| 2022 | 2022-12-30 | $18.1M | $4.5M | +32.71% |
| 2021 | 2021-12-31 | $13.6M | $5.2M | +62.36% |
| 2020 | 2021-01-01 | $8.4M | −$1.7M | −16.75% |
| 2019 | 2020-01-03 | $10.1M | $7.8M | +349.67% |
| 2018 | 2018-12-28 | $2.2M | $1.2M | +114.63% |
| 2017 | 2017-12-29 | $1.0M | −$2.2M | −67.36% |
| 2016 | 2016-12-30 | $3.2M | $1.2M | +56.72% |
| 2015 | 2016-01-01 | $2.0M | −$2.0M | −49.56% |
| 2014 | 2015-01-02 | $4.1M | $606,000 | +17.58% |
| 2013 | 2014-01-03 | $3.4M | $1.2M | +51.83% |
| 2012 | 2012-12-28 | $2.3M | $1.3M | +136.07% |
| 2011 | 2011-12-30 | $962,000 | $642,000 | +200.63% |
| 2010 | 2010-12-31 | $320,000 | −$233,000 | −42.13% |
| 2009 | 2010-01-01 | $553,000 | — | — |
Staar Surgical quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-07-03 | $494,000 | −$1.3M | −72.43% |
| Q1 2026 | 2026-04-03 | $443,000 | −$1.0M | −69.82% |
| Q4 2025 | 2026-01-02 | $1.7M | −$4.0M | −70.71% |
| Q3 2025 | 2025-09-26 | $883,000 | −$5.3M | −85.83% |
| Q2 2025 | 2025-06-27 | $1.8M | −$4.4M | −71.26% |
| Q1 2025 | 2025-03-28 | $1.5M | −$3.7M | −71.78% |
| Q4 2024 | 2024-12-27 | $5.7M | $2.6M | +85.40% |
| Q3 2024 | 2024-09-27 | $6.2M | −$3.0M | −32.16% |
| Q2 2024 | 2024-06-28 | $6.2M | $3.2M | +106.90% |
| Q1 2024 | 2024-03-29 | $5.2M | $2.3M | +79.32% |
| Q4 2023 | 2023-12-29 | $3.1M | −$937,000 | −23.28% |
| Q3 2023 | 2023-09-29 | $9.2M | $2.9M | +46.42% |
| Q2 2023 | 2023-06-30 | $3.0M | −$2.3M | −42.82% |
| Q1 2023 | 2023-03-31 | $2.9M | $362,000 | +14.26% |
| Q4 2022 | 2022-12-30 | $4.0M | −$664,000 | −14.16% |
| Q3 2022 | 2022-09-30 | $6.3M | $3.0M | +91.66% |
| Q2 2022 | 2022-07-01 | $5.3M | $1.7M | +49.57% |
| Q1 2022 | 2022-04-01 | $2.5M | $380,000 | +17.60% |
| Q4 2021 | 2021-12-31 | $4.7M | $2.5M | +118.60% |
| Q3 2021 | 2021-10-01 | $3.3M | $1.2M | +59.74% |
| Q2 2021 | 2021-07-02 | $3.5M | $1.5M | +74.02% |
| Q1 2021 | 2021-04-02 | $2.2M | −$26,000 | −1.19% |
| Q4 2020 | 2021-01-01 | $2.1M | −$781,000 | −26.69% |
| Q3 2020 | 2020-10-02 | $2.0M | −$519,000 | −20.21% |
| Q2 2020 | 2020-07-03 | $2.0M | −$373,000 | −15.55% |
| Q1 2020 | 2020-04-03 | $2.2M | −$18,000 | −0.82% |
| Q4 2019 | 2020-01-03 | $2.9M | $2.4M | +458.40% |
| Q3 2019 | 2019-09-27 | $2.6M | $2.1M | +468.14% |
| Q2 2019 | 2019-06-28 | $2.4M | $2.1M | +688.82% |
| Q1 2019 | 2019-03-29 | $2.2M | $1.2M | +128.29% |
| Q4 2018 | 2018-12-28 | $524,000 | $380,000 | +263.89% |
| Q3 2018 | 2018-09-28 | $452,000 | $107,000 | +31.01% |
| Q2 2018 | 2018-06-29 | $304,000 | −$7,000 | −2.25% |
| Q1 2018 | 2018-03-30 | $965,000 | $719,000 | +292.28% |
| Q4 2017 | 2017-12-29 | $144,000 | −$352,000 | −70.97% |
| Q3 2017 | 2017-09-29 | $345,000 | −$373,000 | −51.95% |
| Q2 2017 | 2017-06-30 | $311,000 | −$674,000 | −68.43% |
| Q1 2017 | 2017-03-31 | $246,000 | −$760,000 | −75.55% |
| Q4 2016 | 2016-12-30 | $496,000 | −$266,000 | −34.91% |
| Q3 2016 | 2016-09-30 | $718,000 | $136,000 | +23.37% |
| Q2 2016 | 2016-07-01 | $985,000 | $612,000 | +164.08% |
| Q1 2016 | 2016-04-01 | $1.0M | $678,000 | +206.71% |
| Q4 2015 | 2016-01-01 | $762,000 | −$775,000 | −50.42% |
| Q3 2015 | 2015-10-02 | $582,000 | $334,000 | +134.68% |
| Q2 2015 | 2015-07-03 | $373,000 | −$482,000 | −56.37% |
| Q1 2015 | 2015-04-03 | $328,000 | −$1.1M | −76.80% |
| Q4 2014 | 2015-01-02 | $1.5M | $1.1M | +231.25% |
| Q3 2014 | 2014-10-03 | $248,000 | −$719,000 | −74.35% |
| Q2 2014 | 2014-07-04 | $855,000 | $56,000 | +7.01% |
| Q1 2014 | 2014-04-04 | $1.4M | $196,000 | +16.09% |
| Q4 2013 | 2014-01-03 | $464,000 | −$646,000 | −58.20% |
| Q3 2013 | 2013-09-27 | $967,000 | $639,000 | +194.82% |
| Q2 2013 | 2013-06-28 | $799,000 | $253,000 | +46.34% |
| Q1 2013 | 2013-03-29 | $1.2M | $931,000 | +324.39% |
| Q4 2012 | 2012-12-28 | $1.1M | $870,000 | +362.50% |
| Q3 2012 | 2012-09-28 | $328,000 | −$187,000 | −36.31% |
| Q2 2012 | 2012-06-29 | $546,000 | $383,000 | +234.97% |
| Q1 2012 | 2012-03-30 | $287,000 | $243,000 | +552.27% |
| Q4 2011 | 2011-12-30 | $240,000 | — | — |
| Q3 2011 | 2011-09-30 | $515,000 | $470,000 | +1044.44% |
| Q2 2011 | 2011-07-01 | $163,000 | — | — |
| Q1 2011 | 2011-04-01 | $44,000 | — | — |
| Q3 2010 | 2010-10-01 | $45,000 | — | — |
Staar Surgical capital expenditures (capex) trends
Over the last five fiscal years, Staar Surgical's capital expenditures (capex) decreased from $8.4M to $5.8M, a change of −$2.6M. The latest reported quarter, Q2 2026, shows $494,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Staar Surgical source filings ↗